Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
alliance, anorexia, Antitrust, Antonio, astrocytoma, bevacizumab, bridging, capability, chose, Darmstadt, developmental, Duke, encountered, Ernst, Francisco, futility, Germany, GIST, glioblastoma, Harbor, headquarter, Herb, highest, Hurwitz, IDMC, Importantly, infrastructure, jointly, light, LLP, magnitude, myeloid, NCCN, Network, ninety, pazopanib, Professor, rationale, RCC, readily, relocation, remedy, retrospectively, San, Science, sorafenib, steering, stromal, sunitinib, Sutent, tiered, train, uncured, unqualified, verify, Votrient, waiting, Young
Removed:
accelerate, adding, aggregating, AllChemie, alleging, assuming, behavior, Boulevard, chairman, choice, compensationprior, Curd, digit, discontinuation, diverting, energy, finalized, furnished, hindsight, index, Janet, John, landlord, Northern, purported, ranging, recognizing, redesigned, regulate, Seaport, sensitive, Supplementary, Swearson, top, unconfirmed, uptake, varied, vessel
Filing tables
Filing exhibits
- 10-K Annual report
- 10.2 2004 Amended and Restated Equity Incentive Plan (As Amended on May 19, 2010)
- 23.1 Consent of Ernst & Young LLP
- 23.2 Consent of Pricewaterhousecoopers LLP
- 31.1 Certification Pursuant to Rule 15D-14 of the Securities and Exchange Act of 1934
- 31.2 Certification Pursuant to Rule 15D-14 of the Securities and Exchange Act of 1934
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350
- 32.2 Certification Pursuant to 18 U.s.c. Section 1350
Related press release
MTEM similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-3 (No. 333-174844, No. 333-169689, 333-162719 and 333-153475) and Registration Statement on Form S-8 (No. 333-173047, No. 333-167260, 333-164865, No. 333-156733, No. 333-126276, No. 333-134598, and No. 333-143130) of Threshold Pharmaceuticals, Inc. of our report dated March 24, 2011 relating to the consolidated financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 15, 2012